02549nam 2200445 450 991079549970332120230809234827.00-309-45565-00-309-45563-4(CKB)4340000000211914(MiAaPQ)EBC4908139(EXLCZ)99434000000021191420170807h20172017 uy 0engurcnu||||||||rdacontentrdamediardacarrierReal-world evidence generation and evaluation of therapeutics proceedings of a workshop /Autumn Downey [and three others], rapporteursWashington, District of Columbia :The National Academies Press,2017.©20171 online resource (86 pages) illustrations0-309-45562-6 Includes bibliographical references at the end of each chapters."The volume and complexity of information about individual patients is greatly increasing with use of electronic records and personal devices. Potential effects on medical product development in the context of this wealth of real-world data could be numerous and varied, ranging from the ability to determine both large-scale and patient-specific effects of treatments to the ability to assess how therapeutics affect patients' lives through measurement of lifestyle changes. In October 2016, the National Academies of Sciences, Engineering, and Medicine held a workshop to facilitate dialogue among stakeholders about the opportunities and challenges for incorporating real-world evidence into all stages in the process for the generation and evaluation of therapeutics. Participants explored unmet stakeholder needs and opportunities to generate new kinds of evidence that meet those needs. This publication summarizes the presentations and discussions from the workshop"--Publisher's description.Evidence-based medicineData processingCongressesEvidence-based medicineData processing616Downey Autumn S.1247374Downey AutumnInstitute of Medicine (U.S.).Forum on Drug Discovery, Development, and Translation.Board on Health Sciences Policy.Health and Medicine Division.MiAaPQMiAaPQMiAaPQBOOK9910795499703321Real-world evidence generation and evaluation of therapeutics3799334UNINA